Aposense Ltd. (Aposense)

Oncology Corporate Profile

HQ Location

5-7 Odem St.
Petach-Tikva, Israel 49170

Company Description

Aposense Ltd. (formerly NST) is a clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo.

Website: http://www.aposense.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
18F-ML-10imaging agentBrain metastasesIIGlaxoSmithKline
ATT-11Tsn38 inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.aposense.com

Recent News Headlines

There are no news items to display